Maeda M
Chest Disease Research Institute, Kyoto University.
Hum Cell. 1992 Mar;5(1):70-8.
HTLV-I is the first human retrovirus that was isolated from a patient with T-cell malignancy in 1980 in the United States. HTLV-I is detected in most patients with adult T cell leukemia (ATL) and healthy carriers, who are frequently found in the southwestern parts of Kyushu and Shikoku Districts. HTLV-I-infected cells express IL-2 receptors, and HTLV-I-infected T cell lines can be established from most of ATL patients in culture in the presence of IL-2. Furthermore, these IL-2 dependent T cell lines often begin to proliferate in the absence of IL-2 and to not respond to IL-2, despite IL-2 receptors on their cell surface, thus mimicking ATL cells in vivo. These findings suggest that HTLV-I is an etiological agent of ATL. In this mini-review, the T cell immortalizing activity of HTLV-I in vitro, with special reference to the evolution of ATL cells based on our results, is described.
人类嗜T淋巴细胞病毒I型(HTLV-I)是1980年在美国从一名患有T细胞恶性肿瘤的患者中分离出的第一种人类逆转录病毒。在大多数成人T细胞白血病(ATL)患者和健康携带者中可检测到HTLV-I,这些患者和携带者常见于九州和四国地区的西南部。HTLV-I感染的细胞表达白细胞介素-2(IL-2)受体,并且在IL-2存在的情况下,可从大多数ATL患者的培养物中建立HTLV-I感染的T细胞系。此外,这些依赖IL-2的T细胞系常常在没有IL-2的情况下开始增殖,并且尽管其细胞表面有IL-2受体,但对IL-2无反应,从而在体内模拟ATL细胞。这些发现表明HTLV-I是ATL的病原体。在这篇小型综述中,将描述HTLV-I在体外的T细胞永生化活性,并特别参考基于我们的研究结果的ATL细胞的演变。